Medical Detox Quality

• International accreditations: NRC holds CARF Three-Year (2024) and WHO Collaborative Centre status; Erada holds CARF (2023), CAP, and Arab Board of Health Specializations Psychiatry Fellowship (2025); Al Amal holds JCI accreditation (first mental health hospital in Middle East)
• Comprehensive medication protocols: Buprenorphine opioid-assisted treatment available since 2003 (first in Arab world); long-acting injectable buprenorphine at Erada with 75.71% full abstinence and retention at 24 weeks in 2023–2024 study; benzodiazepines, naltrexone, and antidepressants authorized by DHA standards
• Physician oversight: Psychiatrist-led multidisciplinary teams at NRC; DHA standards require physician and psychiatrist co-authorization for all detox medications; Erada's Medical Affairs Director has 30+ years addiction psychiatry experience; Arab World's first Addiction Medicine Fellowship program established
• Safety infrastructure: NRC operates 169-bed facility with integrated laboratory services; DHA standards mandate random drug screening at least twice weekly; emergency transfer protocols documented with access to JCI-accredited hospitals; ASSIST and Addiction Severity Index used for assessment
• Access constraints: Government facilities (NRC, Erada) primarily serve Emirati nationals; private sector (Ardens) costs AED 30k–100k/month; historical 2013 WHO EMRO completion rate was only 13% with 34% dropping out; current comprehensive completion rate data not publicly available; nursing-to-patient ratios not documented

Read the full United Arab Emirates report →

• Hospital Carisma operates Colombia's largest methadone program (218 active patients) with multidisciplinary teams integrating psychiatry, psychology, occupational therapy, and nursing; partnerships with Ministry of Justice, US Embassy, and UNODC demonstrate institutional depth [Hospital Carisma de Medellín lidera lucha contra las adicciones — El Tiempo — 2017]
• Evidence-based alcohol withdrawal protocols using CIWA-Ar every 8 hours during acute phase with benzodiazepines (lorazepam, clonazepam, diazepam) and mandated thiamine prophylaxis align with WHO and ASAM standards [Diagnóstico y Manejo del Síndrome de Abstinencia Alcohólica — Encolombia — accessed 2026]
• No addiction-specific facility holds Joint Commission International or CARF accreditation; only 9 general (non-addiction) Colombian hospitals are JCI-accredited [Colombia's Commitment to Quality: Joint Commission International Accreditation Certification Explained — drzamirpaez.com — 2025]
• Buprenorphine remains largely unavailable for opioid withdrawal despite international recommendations for its adoption; researchers explicitly recommended importation to expand treatment options [Alternativas farmacológicas para el tratamiento de la dependencia a la heroína — Revista Colombiana de Psiquiatría — 2014]
• Methadone supply chain fragility documented in 2024: EPS Sura patients in Medellín reported months without dispensed methadone despite FNE safety stock plans [Pacientes con adicciones en Medellín denuncian que Sura no les entrega medicamentos — Blu Radio — 2024]

Read the full Colombia report →

• NHS Inpatient Units led by Consultant Addiction Psychiatrists with 24/7 nursing coverage and mandatory ILS-trained nurses per shift; 2025 DHSC Clinical Guidelines specify comprehensive staffing and monitoring standards
• Alcohol-only completion rate 58% in 2023-24 (below Score 4 threshold of 70-85%); 2017 CQC thematic review found ~two-thirds of 68 residential detox providers not meeting safe care standards
• Comprehensive medication protocols (chlordiazepoxide/diazepam for alcohol, methadone/buprenorphine for opioids) mandated by NICE CG115, NICE CG52, and 2025 DHSC guidelines with mandatory thiamine supplementation
• Mandatory CQC registration with meaningful enforcement; Castle Craig (Outstanding HIS rating, 31+ years ISO 9001); strong safety infrastructure including CIWA-Ar/NEWS2 monitoring, on-site blood work, emergency transfer protocols to acute care
• Limited dedicated medical tourism infrastructure; Castle Craig and Nightingale Hospital serve international patients but primarily English-language services; 60% decline in addiction psychiatry training posts since 2006 creates workforce gaps

Read the full United Kingdom report →

• Public detox completion rate of approximately 55% falls below Score 4 threshold of 70-85%
• Mandatory narcologist supervision with Israel Medical Association-recognized two-year addiction medicine fellowship demonstrates physician competency
• Comprehensive medication protocols available: benzodiazepines for alcohol, buprenorphine/naloxone and methadone for opioids, plus clinical innovation with low-dose buprenorphine (Bernese method) published 2024
• JCI-accredited hospitals (Sourasky/Ichilov, Rambam) provide emergency ICU and cardiac capabilities for withdrawal complications
• Systemic weakness: only ~30% of inpatient completers referred to follow-up services; regulatory tension between health and security ministries undermines care continuity

Read the full Israel report →

• Private facility Zeus Detox offers 24/7 physician and psychiatric supervision with multilingual staff (10 languages) and emergency hospital transfer protocols, but no international accreditation identified
• Public system governed by evidence-based Polish Psychiatric Association guidelines using CIWA-Ar benzodiazepine protocols, but phenobarbital is narcotic-classified (limiting benzodiazepine-resistant cases) and parenteral thiamine >100mg is absent
• Alcohol-related mental health disorder mortality rose from 1,541 deaths (2000) to 5,018 (2023), with age-standardized rate increasing 8.1% annually since 2013; only 15-30% of those meeting clinical criteria for substance use disorders access specialized treatment
• No JCI or CARF accreditation identified for any Polish addiction detox facility; regulatory oversight is limited to RPWDL registry registration; no national mechanism exists for monitoring detox completion rates or complication rates

Read the full Poland report →

• IMH is JCI-accredited since 2005 with maintained recertification cycles, operating as Asia's first JCI-accredited mental health institution
• 24/7 psychiatrist-led medical detoxification with multidisciplinary team including nurses, psychologists, counselors, and medical social workers at a 2,000-bed tertiary psychiatric hospital
• Peer-reviewed RCT (n=111) published in Journal of Substance Abuse Treatment demonstrating evidence-based opioid withdrawal management with lofexidine showing superior treatment retention
• Mandatory CNB reporting within seven days of identifying drug addiction cases creates statutory barrier; major medical tourism platforms explicitly recommend patients seek treatment in Thailand or Bali instead

Read the full Singapore report →

• Ministry of Public Health licensing for multiple established facilities with 3-year CARF accreditation at The Dawn (highest accreditation level)
• 62 JCI-accredited medical partner hospitals in Thailand (July 2024) providing emergency backup capabilities
• Medical directors like Dr. Nattapat Sukkhosawat have specialized addiction medicine training from psychiatric hospitals
• 24/7 awake nursing presence with comprehensive day-2 medical assessment including labs, EKG, and chest X-ray
• Evidence-based medication protocols: long-acting benzodiazepines for alcohol withdrawal, buprenorphine for opioid detox
• Facilities report recovery/success rates of 60-90% but methodologies are undefined and may not specifically measure detox completion
• No publicly disclosed complication rates, seizure incidence, emergency transfer frequencies, or mortality statistics
• Physician on-site availability varies; physicians frequently visit rather than maintain continuous presence; some conduct detox from nearby clinics
• Specific nurse-to-patient ratios not disclosed in available sources
• Some facilities explicitly refuse high-dose opioid replacement therapies, contrary to international best practices

Read the full Thailand report →

• 115 AMATEM centers, 20 ÇEMATEM facilities, and 188 Community Mental Health Centers with 1,388 inpatient beds provide extensive national network coverage [Health, Justice Ministries sign protocol - Daily Sabah - July 11, 2025]
• Opioid substitution treatment using buprenorphine available since 2010 with up to 80% of costs covered by general health insurance, demonstrating evidence-based pharmacological options [THE DRUG PROBLEM IN TURKEY AT A GLANCE - EUDA - 2019]
• Only 45 of 115 AMATEM facilities report treatment demand data, and specific completion rates, complication rates, and mortality statistics are not systematically published at national level [THE DRUG PROBLEM IN TURKEY AT A GLANCE - EUDA - 2019]
• Private JCI-accredited facilities like NPISTANBUL Brain Hospital maintain advanced standards with 24/7 emergency psychiatry service and advanced toxicology laboratories, but these represent only a fraction of the national network [NP BRAIN Clinic - Turquie Santé - Date unknown]
• No documentation of mandated nurse-to-patient ratios during acute withdrawal phases, and sources note that nurse-to-patient ratios often fall short of international standards with staffing shortages in urban centers [How to Hire Nurses in Turkey - Qureos - January 2026]

Read the full Turkey report →

• Brazil has no formally recognized 'Addiction Medicine' specialty—detox is supervised by psychiatrists rather than board-certified addiction medicine physicians, failing Score 4 requirement for addiction medicine training
• Hospital Santa Mônica holds ONA 3 Gold accreditation with 24-hour physician coverage, 200-bed facility, and documented 0.32% in-hospital mortality across 81,608 substance-related hospitalizations in Southern Brazil (2020-2022)
• Benzodiazepines with CIWA-Ar scale are established first-line for alcohol withdrawal; ABP 2024 consensus provides comprehensive evidence-based protocols for alcohol, opioids, cocaine, and polysubstance cases
• Opioid medications (buprenorphine, methadone) classified as 'highly restricted' with prescriber registration limits and 30-day supply caps, constraining medication-assisted detox access
• health-tourism.com listed NO active drug addiction treatment centers for São Paulo; addiction services not systematically organized for international patients unlike Brazil's surgical/oncological medical tourism infrastructure
• Severe geographic disparities: Southeast/South concentrate accredited private capacity and specialized training centers; North/Northeast significantly underserved; 75-85% of Brazilians with mental disorders lack adequate care access
• Quality outcome data (completion rates, complication rates) limited in publicly available form rather than regularly reported to regulatory authorities

Read the full Brazil report →

• Government C&C facilities documented with no on-site physician; PUSPEN has 1 counselor per 500 inmates; psychiatrist visits once weekly
• Government policy mandates 'cold turkey' withdrawal for majority of opioid patients (except age 55+ or medical complications), contradicting WHO guidelines
• PUSPEN historical 70-90% relapse rates; voluntary C&C clinics show improved medication use but completion rates estimated at 30-50%
• Serene Psychology Centre holds Joint Commission accreditation; Solace Asia uses SAMHSA TIP45 protocols with 24/7 medical supervision; private facilities offer multilingual support
• No published in-detox mortality, seizure, or complication rate data publicly available for any Malaysian facility

Read the full Malaysia report →

• Critical shortage of OST-qualified physicians identified as primary barrier; fewer than 700 patients receive state-financed OST nationwide despite 3,200+ estimated high-risk opioid users (under 10% coverage, among lowest in EU)
• National opioid substitution maintenance protocol had expired as of May 2022 with no confirmed replacement; operating without current evidence-based guidelines creates patient safety risk
• Nyírő Gyula OPAI (flagship public addiction facility) explicitly requires patients to complete physical withdrawal before inpatient admission, meaning acute medical detox is managed in general hospital emergency/internal medicine wards without specialized addiction protocols
• Healthcare workforce crisis: 8,500+ healthcare professionals emigrated over past decade; nursing ratios of 4–5 patients per nurse substantially below EU standards; 75% of addiction spending directed to law enforcement vs. 10% to treatment
• OST coverage declined by >10% between 2019–2022 (Hungary one of only 2 EU countries with such decreases); no national registry for detox complications or mortality; quality assurance described as 'nonexistent' across addiction services

Read the full Hungary report →

• Methadone maintenance is entirely prohibited under Japan's Narcotics and Psychotropics Control Act; buprenorphine is available only for inpatient detox at subtherapeutic doses (0.6–1.6 mg/day IM) with no maintenance indication.
• 15% of alcoholic hepatitis inpatients at a Japanese hospital developed delirium tremens during hospitalization, with DT patients frequently losing contact post-acute care and follow-up duration markedly shorter (37 vs. 91 days).
• Formal CIWA-Ar structured assessment for alcohol withdrawal is documented as 'rarely used in practice' despite being the international gold standard, increasing risk of both under- and over-dosing of benzodiazepines.
• No dedicated addiction treatment facility in Japan holds Joint Commission International (JCI) accreditation as of 2026; addiction-specific standards are embedded within psychiatric criteria rather than standalone.

Read the full Japan report →

• 85% of approximately 1,500 rehabilitation centers (1,276 facilities) operated uncertified by CONADIC as of 2017, indicating widespread regulatory non-compliance
• February 2023 closure of Psicofarma, Mexico's only methadone manufacturing plant, created a medication crisis with clinics turning away new clients and limiting doses
• Only 2 government and 16 private clinics nationally provide methadone, with availability restricted to 28-day treatment completion periods
• Research found addiction treatment centers operating without required medical staff including physicians, nurses, counselors, or therapists despite NOM-028-SSA2-2009 requirements
• More than 30% of patients in uncertified centers experience violence during residency, with documented cases of mental health emergencies being punished rather than treated
• Only 4 hospitals in Mexico hold Joint Commission International (JCI) accreditation with none specifically providing addiction treatment services

Read the full Mexico report →

• An estimated 70 percent of de-addiction centers lack standard treatment and care facilities, with many unregistered and unlicensed.
• Documented incidents of staff members physically abusing patients, sometimes resulting in fatalities, and deaths of inmates attempting to flee facilities.
• Methadone maintenance retention rates of 35.9% at one year and short-term relapse rates as high as 80%, well below acceptable completion rates.
• No uniform national regulatory framework applies to private or NGO-run facilities; regulatory standards vary by state.
• Most facilities do not follow internationally accepted norms with poor infrastructure and shortage of trained staff to handle medical and psychiatric needs during detoxification.

Read the full India report →

• Severe psychiatric staffing shortage: fewer than 1 psychiatrist per 100,000 population (87 total for Jordan's 10+ million) and only 0.13 psychiatric nurses per 100,000
• OAT (methadone/buprenorphine) infrastructure absent until UNODC-supported expansion in 2024; previously not a routine element of opioid withdrawal management
• Zero independent clinical accreditation: no addiction/psychiatric facilities hold HCAC or JCI certification; Al Rashid's only accreditation is from Arab Board of Psychiatry for training purposes
• No published outcome data: specific completion rates and complication incidence not publicly documented; 2021 data showed only 100+ people in treatment versus 14,129+ charged with drug possession, indicating systemic underutilization
• Severe capacity mismatch: three facilities totaling 357 beds serve a country facing escalating substance use with 25,260 drug-related cases in 2024

Read the full Jordan report →

• The 3 WHO-approved medications, methadone, buprenorphine, and naltrexone ER, are currently not available — critical gap for opioid withdrawal management
• Only 292 designated beds across 24 facilities nationally (0.57 beds per 100,000 population) — severely inadequate capacity
• No specific published data on detoxification completion rates, complication rates, or mortality during medical detox — lack of outcome transparency
• Korea lacks formal addiction medicine specialty certification; psychiatrists oversee detox without addiction medicine board certification equivalent to international standards
• Nurse-to-patient ratios 1:6-1:10 in general settings with unclear addiction nursing training requirements
• Evidence-based alcohol withdrawal protocols using symptom-triggered therapy with lorazepam (up to 20 mg/day for severe withdrawal) — represents the primary strength

Read the full South Korea report →